Pricing Log in Create free account

Grifols, S.A. (GRFS) vs GSK PLC Sponsored ADR (GSK)

Grifols, S.A. and GSK PLC Sponsored ADR are both Drug Manufacturers General companies. GSK PLC Sponsored ADR is the larger, with a market value of $101.0B against $2.2B — 46.3× the size. GSK PLC Sponsored ADR trades at the lower P/E: 16.7× against 18.2×. Grifols, S.A. grew revenue faster over the last twelve months: 10.9% against 6.90%. GSK PLC Sponsored ADR has the higher net margin (13.0% vs 6.02%) and the higher return on invested capital (9.61% vs 4.76%). Both pay a dividend; GSK PLC Sponsored ADR yields more (3.61% vs 1.12%). Across the 23 metrics below, GSK PLC Sponsored ADR leads on 12 and Grifols, S.A. on 11.

Valuation

Metric GRFS GSK Drug Manufacturers General median
P/E 18.23 16.70 26.51
P/S 0.65 2.24 3.49
P/B 0.60 4.08 5.28
Price to free cash flow 7.65 11.42 21.67
EV/EBITDA 8.40 10.54 14.73
EV/Sales 1.77 2.86 4.15
Earnings yield 5.49% 5.99% 2.41%
Free cash flow yield 13.08% 8.76% 4.07%

Profitability

Metric GRFS GSK Drug Manufacturers General median
Gross margin 37.55% 72.64% 73.01%
Operating margin 16.69% 17.95% 18.34%
Net margin 6.02% 13.02% 7.31%
Free cash flow margin 8.51% 19.65% 18.56%
Return on equity 5.80% 25.48% 5.80%
Return on assets 2.28% 6.53% 2.28%
Return on invested capital 4.76% 9.61% 6.26%

Growth

Metric GRFS GSK Drug Manufacturers General median
Revenue growth (TTM) 10.87% 6.90% 6.72%
EPS growth (last fiscal year) 168.00% 133.96% 21.81%
Revenue growth, 5-year CAGR 6.89% (0.32%) 4.75%
Net income growth, 5-year CAGR (8.43%) 0.42% 0.00%

Health

Metric GRFS GSK Drug Manufacturers General median
Debt to equity 1.12 1.29 0.62
Current ratio 2.33 0.86 1.39
Net debt to EBITDA 5.19 1.39 1.15

Dividend

Metric GRFS GSK Drug Manufacturers General median
Dividend yield 1.12% 3.61% 2.32%
Payout ratio 0.20 0.61 0.59

Size

Metric GRFS GSK Drug Manufacturers General median
Market cap 2.18b 101.04b 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack